What's hot

View all perspectives
What's Hot

JAK Safety -- The Lowdown on Infection: Drs. Kevin Winthrop and Jonathan Kay

Watch video →

RheumNow Rheumatology Roundup: Drs. Kavanaugh and Cush

Rheumatology Roundup! Drs. Cush and Kavanaugh convene for their annual impromptu review of some of the best and more interesting abstracts presented at ACR 2021.    

Watch video →

TNF Inhibitor Panel Discussion: ACR21 Annual Meeting

RheumNow TNFi faculty convened to discuss several TNFi-related abstracts presented at ACR 21. Panelists: Drs. Aurelie Najm, Janet Pope, David Liew, Eric Dein and Swetha Alexander. 

Watch video →

Spondyloarthritis Panel Discussion: ACR21 Meeting

Panelists: Drs. Antoni Chan, Robert Chao, Rachel Tate, Sheila Reyes and Akhil Sood. Abstracts discussed include #0562, #1919, #0907, #0364 and #0919

Watch video →

Might Tofacitinib Reduce Malignancy Risk with Patients with RA? Dr. Jonathan Kay

Dr. Kay discusses abstract 1940 and abstract 980 presented at the ACR21 annual meeting.

Watch video →

Diagnosing (Bad) VEXAS: The Experts Speak Drs. Beck and Ferrada

Dr. Cush discusses Dr. Marcela Ferrada and Dr. David Beck to discuss VEXAS syndrome and abstract 1426, which was presented at the ACR21 annual meeting.

Watch video →

Pediatric Psoriatic Arthritis: Dr. Eric Ruderman

Dr. Ruderman discusses abstracts #1424 presented at the ACR21 annual meeting.

Watch video →

Urine Proteome Advances: What Do They Mean? Dr. Michelle Petri

Dr. Petri reviews abstracts #1422 and #1936, presented at the ACR21 annual meeting.

Watch video →

ACR21 Day 3 Recap: Polypharmacy, New Lupus Drugs, VEXAS, Safety Data

Blurb: Drs. Jack Cush and the RheumNow Faculty Drs. Akhil Sood, Antoni Chan, Olga Petryna and Eric Dein, discuss highlights from Day 3 (Monday) at the ACR21 annual meeting. Abstracts include #1367, #1044, #1444, #1083 and more.

Watch video →

Cardiovascular Disease for TNFi vs JAKi: Dr Jon Giles

Dr. Giles discusses abstracts #0831and #0958 presented at the ACR21 annual meeting.

Watch video →

Predictors of TNF Response with Drs. Pope, Dein and Liew

Drs. Janet Pope, David Liew and Eric Dein discuss TNF data presented at the ACR21 annual meeting, including abstracts #1251, #1442, #1448.

Watch video →

Caring for the Older Patient with Rheumatic Disease: Drs. Makris, Yung and Dao

Drs. Kathryn Dao, Una Makris and Raymond Yung discuss the field of geriatric rheumatology and caring for the older patient with rheumatic disease.

Watch video →

Autoinflammatory: PAH in AOSD, VEXAS, JAKi in Still's, Role of labs in infections vs. flares

  Drs. Jack Cush, Yuz Yusof, Bella Mehta, Olga Petryna and Rachel Tate review autoinflammatory data presented at the ACR21 annual meeting, including abstracts #1100, #1062, #1426, #0252, #0195, and #1083.

Watch video →

FDA Session Review: Dr. Arthur Kavanaugh

Dr. Kavanaugh discussed the FDA session presented at the ACR21 annual meeting, including safety data and new approvals and indications in several rheumatic diseases, including lupus, ANCA-associated vasculitis, lupus nephritis and more.

Watch video →

The Respiratory Tract and RA with Drs. Sparks, McDermott and Kronzer

Drs. Jeffrey Sparks, Greg McDermott and Vanessa Kronzer discuss work in the area of respiratory disease in RA, mucosal paradigm, RA-ILD, bronchiectasis, as well as their experience as virtual attendees at the ACR21 annual meeting.

Watch video →

Pulmonary Hypertension in Adult Onset Still's Disease: Dr. Jack Cush

Dr. Cush reviews poster #1100 presented at the ACR21 annual meeting.

Watch video →

Data on Existing SLE Medications, Patient Centered Outcomes, and Exercise: Dr. Michelle Petri

Dr. Petri discusses data on existing SLE medications, patient-centered outcomes and the importance of exercise, presented Monday at the ACR21 annual meeting.

Watch video →

ACR21 Day 2 Recap: CV Risk, Tapering in SpA, Microbiome in PsA, Vit D

Drs. Jack Cush and the RheumNow Faculty Drs. David Liew, Swetha Ann Alexander, Meral El Ramahi, Mrinalini Dey and Robert Chao, discuss highlights from Day 2 (Sunday) at the ACR21 Virtual meeting.

Watch video →
      RT @RichardPAConway: Dr Keen presenting on GCA admitted to hospital. Propensity score matched to non-GCA population. Inc

      Richard Conway RichardPAConway

      4 years ago
      Dr Keen presenting on GCA admitted to hospital. Propensity score matched to non-GCA population. Increased all cause mortality compared to general population in Western Australia (aHR 1.13). Most pronounced in early years after diagnosis. Abstr#1393 #ACR21 @RheumNow https://t.co/laW8mxp6uq
      RT @DrMiniDey: Dr Björn Bühring highlights the burden of #multimorbidity and particularly #sarcopenia in older patient

      Mrinalini Dey DrMiniDey

      4 years ago
      Dr Björn Bühring highlights the burden of #multimorbidity and particularly #sarcopenia in older patients with #rheumatoidarthritis. #ACR21 @RheumNow https://t.co/3xGtx48DAU
      RT @uptoTate: Majority of rheum pts on csDMARDs, TNFi, JAKi & TCZ had adequate serologic response to m-RNA based vac

      Dr. Rachel Tate uptoTate

      4 years ago
      Majority of rheum pts on csDMARDs, TNFi, JAKi & TCZ had adequate serologic response to m-RNA based vaccines. Poor vaccine reactivity mainly assoc'd w/ RTX, steroids, and MMF. Study did not include ABA. Abs 1087 #ACR21 #RheumNow #ACRbest @RheumNow https://t.co/q4C66Htz5a https://t.co/MS7cqdFWBi
      RT @DrPetryna: Abst1083 #acr21 #ACRBest @RheumNow study of COVID-19 outcomes in pts w/systemic auto inflammatory disease

      Olga Petryna DrPetryna

      4 years ago
      Abst1083 #acr21 #ACRBest @RheumNow study of COVID-19 outcomes in pts w/systemic auto inflammatory disease:31% had a flare of underlying SAID, either concurrently (20%) or after recovering from COVID-19 (11%). The majority of SAID pts w/COVID-19 reported mild to moderate illness https://t.co/qzYfmYpA25
      RT @DrMiniDey: Important to properly assess #sarcopenia in older patients with #RA. Useful tools include:
      👉🏼SARC-F

      Mrinalini Dey DrMiniDey

      4 years ago
      Important to properly assess #sarcopenia in older patients with #RA. Useful tools include: 👉🏼SARC-F questionnaire (≥ 4 is abnormal) 👉🏼Muscle function tests incl Short Physical Performance Battery #ACR21 @RheumNow https://t.co/9l6b7tJ1xC
      RT @uptoTate: Retrospective French case study showed PAH is rare but potentially severe complication of AOSD. In this tr

      Dr. Rachel Tate uptoTate

      4 years ago
      Retrospective French case study showed PAH is rare but potentially severe complication of AOSD. In this trial of 13, it only affected women. Further studies needed! Abs 1100 #ACR21 #RheumNow @RheumNow https://t.co/6CufqRV0Qg https://t.co/h73mxsJswi
      RT @DrPetryna: Abst1094 #acr21 @RheumNow rheum pts and extremely ⬆️ESR: infection vs flare: Thrombocyte, MCV, albumi

      Olga Petryna DrPetryna

      4 years ago
      Abst1094 #acr21 @RheumNow rheum pts and extremely ⬆️ESR: infection vs flare: Thrombocyte, MCV, albumin and total protein were significantly lower in infection group, however; neutrophil, MPV, CRP and ferritin were significantly lower in flare-up group https://t.co/C6MQo86Ljb
      RT @_Castillo_Pedro: Urinary CD163: Potential Biomarker in LN
      💠Correlated w/histological activity
      💠⬆️in prolif

      Pedro Castillo _Castillo_Pedro

      4 years ago
      Urinary CD163: Potential Biomarker in LN 💠Correlated w/histological activity 💠⬆️in prolif LN 💠⬇️in responders 💠Clinical features + biomarkers may provide non-invasive method to dx and monitor response in LN https://t.co/u910ehQH74 #ACR2021 Abst#1422 @RheumNow #ACRBest
      RT @drdavidliew: TCZ in COVID-19: studies that form the basis of the EUA, direct from the @US_FDA

      (now can we have enou

      David Liew drdavidliew

      4 years ago
      TCZ in COVID-19: studies that form the basis of the EUA, direct from the @US_FDA (now can we have enough for our RA, GCA, and JIA pts still on it, please @genentech @Roche?) #ACR21 FDA update @RheumNow https://t.co/ZQv9XtoRJZ
      RT @KDAO2011: “Geriatrics is a team sport!” – Dr. Buehring #ACR11 @rheumnow @UnaMakris #GeriRheum #aging https://

      TheDaoIndex KDAO2011

      4 years ago
      “Geriatrics is a team sport!” – Dr. Buehring #ACR11 @rheumnow @UnaMakris #GeriRheum #aging https://t.co/ckAJsi696Y
      RT @Yuz6Yusof: #ACR21 #Abstr Are we close to not needing kidney biopsy to assess #lupus nephritis? A study showed Urinar

      Md Yuzaiful Md Yusof Yuz6Yusof

      4 years ago
      #ACR21 #Abstr Are we close to not needing kidney biopsy to assess #lupus nephritis? A study showed Urinary CD163: ⬆️in proliferating LN ⬇️in responders with good AUC Further works: ?marker for flare, how sensitive vs uPCR, different therapies @RheumNow https://t.co/d0quh9wu5h https://t.co/zWm8SJvRXz
      RT @uptoTate: Hip involvement/TJR assoc'd w/ MEFV+ vs HLA-B27+ in FMF/SpA pts vs SpA. FMF/SpA: more severe disease, wors

      Dr. Rachel Tate uptoTate

      4 years ago

      Hip involvement/TJR assoc'd w/ MEFV+ vs HLA-B27+ in FMF/SpA pts vs SpA. FMF/SpA: more severe disease, worse outcomes, & destructive hip involvement vs SpA, particularly in pts with MEFV variants & M694V homozygosity. Abs 1108 #ACR21 #RheumNow @RheumNow https://t.co/hlnN26AYgE https://t.co/1jHeVxKs7O

      RT @AkhilSoodMD: Very interesting talks by @UnaMakris and #DrBuhring on Multicomplexity in the Aging Patient with #RA
      #A

      Akhil Sood MD AkhilSoodMD

      4 years ago
      Very interesting talks by @UnaMakris and #DrBuhring on Multicomplexity in the Aging Patient with #RA #ACR21 @RheumNow https://t.co/WA8YtEpKhk
      RT @RichardPAConway: Open label study of only 8 weeks of steroid with tocilizumab for 1 year in GCA. 74% sustained stero

      Richard Conway RichardPAConway

      4 years ago
      Open label study of only 8 weeks of steroid with tocilizumab for 1 year in GCA. 74% sustained steroid free remission at 1 year. Wow! Needs an RCT. Abstr#1413 #ACR21 @RheumNow https://t.co/c82qGJCFip
      RT @KDAO2011: “NSAIDS are not off the table for older adults!” – Dr @unamakris says use⬇️dose &monitor; GF

      TheDaoIndex KDAO2011

      4 years ago
      “NSAIDS are not off the table for older adults!” – Dr @unamakris says use⬇️dose &monitor; GFR may be misleading (toxicity seen w/normal Cr) She’s not a fan of tramadol, but recc topical pain meds, SSRI/NSRI, short-acting⬇️dose opioids when acet & nonpharm Rx fail @rheumnow #ACR21 https://t.co/rLeEagwrQU

      Podcasts

      • Giant Cell Arteritis and Polymyalgia Rheumatic Wrapup: Drs. Calabrese, Liew, Conway and Mackie 00:20:18
      • Reproductive Health in Rheumatic Diseases: Drs. Bermas, Buyon and Dao 00:20:26
      • The Expert Gout Panel with Drs. Neogi, Saag, Pillinger, Cush and O'Dell 00:35:26

      Catch up on Conference Podcasts

      ×